Stockley's drug interactions : a source book of interactions, their mechanisms, clinical importance and management
著者
書誌事項
Stockley's drug interactions : a source book of interactions, their mechanisms, clinical importance and management
Pharmaceutical Press, 2010
9th ed. / edited by Karen Baxter
- : book
- : CD-ROM
- : CD-ROM + book
大学図書館所蔵 全5件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Accompanied by 1 computer laser optical disc "Stockley's drug interactions 9" (4 3/4 in.)
Includes index
内容説明・目次
内容説明
Stockley's Drug Interactions, edited by Karen Baxter, remains the world's most comprehensive and authoritative reference book on drug interactions. * Contains detailed yet concise monographs * Covers interactions between therapeutic drugs, proprietary medicines, herbal medicines, foods, drinks, pesticides and drugs of abuse * Based on published sources and fully referenced * Provides comprehensive details of the clinical evidence for the interactions under discussion, an assessment of their clinical importance and gives clear guidance on how to manage the interaction in practice * Contains over 3,400 monographs New for the 9th edition: * Over 300 new monographs * All monographs fully revised and revalidated * Three new chapters on the interactions of Thyroid Hormones, Urological drugs, and Nutritional agents, Supplements and Vitamins * New drugs launched in the last two years added - including drugs such as fesoterodine, several monoclonal antibodies, new antidiabetics (e.g. sitagliptin) new antineoplastics (e.g. dasatinib) and new immunosuppressants (e.g. temsirolimus) * Updated information on seasonal flu vaccines and antivirals, including all available information on possible interactions with concurrent medication * Increased commentary on the involvement of newer mechanisms in drug interactions, such as drug transporter proteins, and other genetic factors that affect the ability of individuals to metabolise medicines
「Nielsen BookData」 より